Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3.

Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, Witko-Sarsat V, Perretti M.

J Biol Chem. 2007 Oct 12;282(41):29998-30004. Epub 2007 Aug 6.

2.

Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.

Pederzoli-Ribeil M, Maione F, Cooper D, Al-Kashi A, Dalli J, Perretti M, D'Acquisto F.

Blood. 2010 Nov 18;116(20):4288-96. doi: 10.1182/blood-2010-02-270520. Epub 2010 Aug 12.

3.

Cleavage of annexin I in human neutrophils is mediated by a membrane-localized metalloprotease.

Movitz C, Sjölin C, Dahlgren C.

Biochim Biophys Acta. 1999 Jan 12;1416(1-2):101-8.

4.

A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration.

Williams SL, Milne IR, Bagley CJ, Gamble JR, Vadas MA, Pitson SM, Khew-Goodall Y.

J Immunol. 2010 Sep 1;185(5):3057-63. doi: 10.4049/jimmunol.1000119. Epub 2010 Aug 2.

5.

Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Perretti M, Dalli J.

Br J Pharmacol. 2009 Oct;158(4):936-46. doi: 10.1111/j.1476-5381.2009.00483.x. Review.

6.

Expression of annexin-1 in equine leucocytes and the effects of the N-terminal annexin-1 peptide, Ac2-26, on equine neutrophil superoxide production.

Pickles KJ, Brooks AC, Rickards KJ, Cunningham FM.

Vet Immunol Immunopathol. 2010 Jun 15;135(3-4):226-33. doi: 10.1016/j.vetimm.2009.12.002. Epub 2009 Dec 16.

PMID:
20079938
7.

The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1.

Movitz C, Brive L, Hellstrand K, Rabiet MJ, Dahlgren C.

J Biol Chem. 2010 May 7;285(19):14338-45. doi: 10.1074/jbc.M109.080465. Epub 2010 Mar 10.

9.

Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.

Kantari C, Pederzoli-Ribeil M, Amir-Moazami O, Gausson-Dorey V, Moura IC, Lecomte MC, Benhamou M, Witko-Sarsat V.

Blood. 2007 Dec 1;110(12):4086-95. Epub 2007 Aug 21.

10.

Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus.

Perretti M, Wheller SK, Choudhury Q, Croxtall JD, Flower RJ.

Biochem Pharmacol. 1995 Sep 28;50(7):1037-42.

PMID:
7575659
11.

New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.

Guarino C, Legowska M, Epinette C, Kellenberger C, Dallet-Choisy S, Sieńczyk M, Gabant G, Cadene M, Zoidakis J, Vlahou A, Wysocka M, Marchand-Adam S, Jenne DE, Lesner A, Gauthier F, Korkmaz B.

J Biol Chem. 2014 Nov 14;289(46):31777-91. doi: 10.1074/jbc.M114.591339. Epub 2014 Oct 6.

12.

Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.

Girol AP, Mimura KK, Drewes CC, Bolonheis SM, Solito E, Farsky SH, Gil CD, Oliani SM.

J Immunol. 2013 Jun 1;190(11):5689-701. doi: 10.4049/jimmunol.1202030. Epub 2013 May 3.

13.

Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide.

Perretti M, Di Filippo C, D'Amico M, Dalli J.

PLoS One. 2017 Apr 13;12(4):e0175786. doi: 10.1371/journal.pone.0175786. eCollection 2017.

14.

Modulation of equine neutrophil adherence and migration by the annexin-1 derived N-terminal peptide, Ac2-26.

Brooks AC, Rickards KJ, Cunningham FM.

Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):214-22. doi: 10.1016/j.vetimm.2011.11.011. Epub 2011 Nov 19.

PMID:
22197008
15.

Differential modulation of annexin I binding sites on monocytes and neutrophils.

Euzger HS, Flower RJ, Goulding NJ, Perretti M.

Mediators Inflamm. 1999;8(1):53-62.

16.

Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.

Ryu OH, Choi SJ, Firatli E, Choi SW, Hart PS, Shen RF, Wang G, Wu WW, Hart TC.

J Biol Chem. 2005 Apr 29;280(17):17415-21. Epub 2005 Feb 22.

17.

Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors.

Montero-Melendez T, Dalli J, Perretti M.

Cell Death Differ. 2013 Apr;20(4):567-75. doi: 10.1038/cdd.2012.154. Epub 2012 Dec 7.

18.

Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.

Tsao FH, Meyer KC, Chen X, Rosenthal NS, Hu J.

Am J Respir Cell Mol Biol. 1998 Jan;18(1):120-8.

PMID:
9448053
19.

Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients.

Bensalem N, Ventura AP, Vallée B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprévote O, Edelman A.

Mol Cell Proteomics. 2005 Oct;4(10):1591-601. Epub 2005 Jul 12.

20.

Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation.

Loison F, Zhu H, Karatepe K, Kasorn A, Liu P, Ye K, Zhou J, Cao S, Gong H, Jenne DE, Remold-O'Donnell E, Xu Y, Luo HR.

J Clin Invest. 2014 Oct;124(10):4445-58. doi: 10.1172/JCI76246. Epub 2014 Sep 2.

Supplemental Content

Support Center